Tolvaptan

Tolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28μM for the inhibition of AVP-induced platelet aggregation.IC50 value: 1.28 uM (inhibition of AVP-induced platelet aggregation)Target: vasopressin receptor 2Tolvaptan (OPC-41061) is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28μM for the inhibition of AVP-induced platelet aggregation. Tolvaptan (OPC-41061) is used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH). Tolvaptan (OPC-41061) is also in fast-track clinical trials for polycystic kidney disease. Treatment with t tolvaptan (OPC-41061) causes rapid and sustained body weight reductions concurrent with increases in urine output, improves and/or normalizes serum sodium in hyponatremic patients, reduces signs and symptoms of congestion and increases thirst. However, tolvaptan (OPC-41061) has not been shown to decrease heart failure re-hospitalization or mortality. As an adjunct to standard therapy, tolvaptan (OPC-41061) is unique in that it is virtually the only novel agent tested in patients hospitalized for acute heart failure syndrome (AHFS) to reach its primary end point for short-term efficacy without causing deleterious side effects.

CAS: 40064-34-4  4-Piperidone monohydrate hydrochloride

CAS: 459-03-0           (4-Fluorophenyl)acetone
 
CAS:6080-56-4             Lead acetate trihydrate;Acetic acid

CAS:96-48-0         2-oxo-tetrahydrofurane

CAS: 64-17-5            Ethanol  

CAS:49851-31-2        2-bromo-1-phenylpentan-1-one

  CAS:103-63-9           Benzene, (2-bromoethyl)-

CAS:23076-35-9           Xylazine hydrochloride

CAS：103-81-1         Phenylacetamide

CAS: 99-92-3            4-Aminoacetophenone

CAS: 37148-48-4         4-Amino-3,5-dichloroacetophenone

CAS: 37148-47-3          4-Amino-3,5-dichlorophenacylbromide

CAS: 100-09-4         4-methoxybenzoic acid  

CAS: 100-07-2          4-Methoxybenzoyl chloride

CAS:23426-63-3        methyl 2-bromo-2-methylpropanoate

CAS:16595-80-5        Levamisole hydrochloride

CAS:5445-19-2          Methyl 2-Bromohexanoate

CAS:600-00-0           Ethyl 2-Bromoisobutyrate

CAS:1451-83-8         2-bromo-1-(3-methylphenyl)propan-1-one

CAS:49851-31-2         α-Bromovalerophenone
 
CAS:41979-39-9       4-oxopiperidinium chloride

CAS:56786-63-1       Spirostan-?6-?one, 3,?5-?dihydroxy-?, (3β,?5α,?25R)?-       
 
CAS:593-51-1           methylamine hydrochloride
 
CAS:5337-93-9         4-methylpropiophenone  
 
CAS:73-78-9         lidocaine hydrochloride

137-58-6             Lidocaine

CAS:136-47-0         Tetracaine hydrochloride

CAS: 138-59-0          Shikimic acid

CAS:94-09-7   Benzocaine    

CAS:94-15-5            Dimethocaine (Larocaine)

CAS:94-24-6            tetracaine

CAS:23239-88-5         ethyl 4-aminobenzoate,hydrochloride  

CAS:4584-49-0     2-(Dimethylamino)Isopropyl Chloride Hydrochloride

CAS:705-60-2          2-nitro-1-phenyl-1-propene

131707-25-0        ethyl 6-bromo-4-[(dimethylamino)methyl]  

CAS:78-67-1          2,2'-Azobis(2-methylpropionitrile)

CAS:  2893-78-9              Sodium dichloroisocyanurate